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Background: The export of intron containing viral RNAs from the nucleus to the cytoplasm is an essential step in
the life cycle of Human Immunodeficiency Virus-1 (HIV-1). As the eukaryotic system does not permit the transport
of intron containing RNA out of the nucleus, HIV-1 makes a regulatory protein, Rev, that mediates the transportation
of unspliced and partially spliced viral mRNA from the nucleus to the cytoplasm, thereby playing a decisive role in
the generation of new infectious virus particles. Therefore, the host factors modulating the RNA export activity of
Rev can be major determinants of virus production in an infected cell.
Results: In this study, human Staufen-2 (hStau-2) was identified as a host factor interacting with HIV-1 Rev through
affinity chromatography followed by MALDI analyses. Our experiments involving transient expressions, siRNA mediated
knockdowns and infection assays conclusively established that hStau-2 is a positive regulator of HIV-1 pathogenesis. We
demonstrated that Rev-hStau-2 interactions positively regulated the RNA export activity of Rev and promoted progeny
virus synthesis. The Rev-hStau-2 interaction was independent of RNA despite both being RNA binding proteins. hStau-2
mutant, with mutations at Q314R-A318F-K319E, deficient of binding Rev, failed to promote hStau-2 dependent Rev
activity and viral production, validating the essentiality of this protein-protein interaction. The expression of this positive
regulator was elevated upon HIV-1 infection in both human T-lymphocyte and astrocyte cell lines.
Conclusions: With this study, we establish that human Staufen-2, a host factor which is up-regulated upon HIV-1
infection, interacts with HIV-1 Rev, thereby promoting its RNA export activity and progeny virus formation. Altogether,
our study provides new insights into the emerging role of the Staufen family of mRNA transporters in host-pathogen
interaction and supports the notion that obliterating interactions between viral and host proteins that positively regulate
HIV-1 proliferation can significantly contribute to anti-retroviral treatments.
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Human Immunodeficiency Virus-1 (HIV-1) is a pathogenic
retrovirus that cripples the human immune system making
it susceptible to several opportunistic infections and malig-
nancies, leading to Acquired Immunodeficiency Syndrome
(AIDS) [1-4]. Like all other successful intracellular patho-
gens, HIV also establishes dynamic biological interactions
with the host cell machinery for persistence and pathogen-
esis. HIV-1, during the course of infection, makes com-
pletely spliced, partially spliced and unspliced mRNAs for* Correspondence: sbsl@uohyd.ernet.in
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stated.the synthesis of viral proteins to generate new virion parti-
cles [5]. While completely spliced viral mRNA utilizes
the constitutive mRNA nuclear export pathway of the
eukaryotic cells [6], the partially spliced and the unspliced
viral mRNAs are retained in the nuclei of the infected host
cells for further splicing or degradation. HIV overcomes
this problem by synthesizing a protein called Rev (Regula-
tor of virion expression) from completely spliced viral
mRNA [7]. Rev is a 18 kDa nucleo-cytoplasmic transport
protein that tethers to Rev responsive element (RRE)
present within the partially spliced and the unspliced viral
mRNA and facilitate their export to the cytoplasm for the
translation and progeny virus synthesis [8]. Rev, therefore,
is an essential protein of the virus, the inactivation orl Ltd. This is an Open Access article distributed under the terms of the Creative
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particles [5].
Under physiological conditions, Rev shuttles between
the cytoplasmic and the nuclear compartments where it
interacts with several host factors that modulate its
activity, consequently affecting HIV proliferation. Host
nuclear proteins such as Matrin-3, RNA helicases,
PSF, Rab/hRIP and CRM-1/exportin-1 that interact with
Rev mediate its export from the nucleus to the cytoplasm
[9-16]. Host proteins, such as, Ataxia-telangiectasia-mutated
(ATM) protein [17], eukaryotic Initiation Factor-5a [18],
Sam68 [19] and DEAD box RNA helicases [20], function as
positive effectors of Rev activity, while factors such as, anti-
apoptotic mitochondrial protein, HS1-associated protein
X-1 (Hax-1), negatively regulate the function of HIV-1 Rev
by perturbing its sub-cellular distribution [21]. Some host
proteins, which prevent effective binding of Rev to RRE,
such as Rev Response Element Binding Protein of 49 kDa
(RREBP49) [22] or Alternate splicing factor (SF2/ASF) [23]
interferes with the export activity of Rev, thereby reducing
the virion particle formation. Apart from host factors, viral
proteins also play a role in the sub-cellular localization of
Rev which can eventually affect its activity [24]. An exhaust-
ive list of the possible host factors interacting with HIV-1
has been reported by Jager et. al [25].
Acting as a post-transcriptional regulator of HIV-1
gene expression, identifying the cellular factors modulat-
ing Rev activity is highly pertinent to understand the
pathogenicity of HIV-1. We hypothesized that cell spe-
cific host factors modulating the activity of Rev can serve
as determinants in viral propagation and pathogenesis.
Therefore, we attempted to capture Rev-interacting hu-
man cellular factors by making a Rev-affinity column,
where purified recombinant histidine tagged HIV-1 Rev
was used as bait. We characterized the interaction be-
tween Rev and a double-stranded RNA-binding host pro-
tein Staufen-2, identified from SUP-T1 (Human T cell
lymphoblastoma) cell lysates. Human Staufen homolog 2
(hStau-2) is a double-stranded-RNA binding protein, with
multiple splice variants [26] that possibly, like other mam-
malian Staufen homologs, forms ribonucleoprotein com-
plexes (RNPs) [27]. hStau-2 has been shown to participate
in targeted packaging and localization of mRNA in polar-
ized cells and is a part of stress granules in neurons.
hStau-2 has also been observed in other cell types includ-
ing cell lines like HeLa and 293 F [28,29].
In this study, the intracellular interactions between
Rev and hStau-2 were validated by transient expression
of both the proteins in cell lines followed by co-
immunoprecipitations. Ectopic and transient expres-
sions, sub-cellular localizations, siRNA knockdowns and
infection assays using wild type and mutant hStau-2
confirmed that the interaction of hStau-2 with Rev posi-
tively regulated the RRE containing RNA export activityof Rev and promoted progeny virus synthesis. Further-
more, HIV-1 infection elevated the expression of hStau-2
in both human T-lymphocyte and astrocyte cell lines.
With these observations, we conclude that hStau-2, better
known for its role in mRNA transportation and stress
granule formation in neural cells [30], assumes a novel
regulatory role during HIV-1 infection contributing to our
existing knowledge of HIV-host interactions.
Results
Human Staufen-2 (hStau-2) interacted with HIV-1 Rev
protein in RNA independent manner
Purified recombinant polyhistidine tagged HIV-1 Rev
(Additional file 1: Figure S1A), immobilized on Talon
resin, was used to pull-down Rev interacting host factors
from SUP-T1 (Human T cell lymphoblastoma) cell ly-
sates (Additional file 1: Figure S1B). An endogenously
expressed double stranded RNA binding host protein,
human Staufen-2 (hStau-2), was identified after MALDI
analyses as one of the proteins in pull-down samples
showing significant MASCOT score (Additional file 1:
Figure S1C and Additional file 2: Figure S2). The inter-
action was further confirmed by co-immunoprecipitation
of endogenously expressed hStau-2 from HEK293T cell
lysates with transiently expressed GFP-tagged Rev (Rev-
GFP). Rev-GFP was immunoprecipitated with mouse anti-
Rev antibody and hStau-2 was detected by Western blot in
the immunoprecipitated samples using goat anti-hStau-2
antibody (Figure 1A). HEK293T cells transfected with
empty GFP vector was used as a control and did not show
any hStau-2 signal (Figure 1A). The same was confirmed
by immunoprecipitation with anti-GFP antibody followed
by Western Blot with hStau-2 antibody (Figure 1B). These
data clearly demonstrated that transiently expressed Rev
could interact with the endogenous hStau-2 intracellularly
in HEK293T cells.
hStau-2 and Rev, both are RNA binding proteins. We,
therefore, questioned if the cellular RNA mediated the
Rev-hStau-2 interactions. For this, Rev-GFP and hStau-2
were transiently co-expressed in HEK293T cells and the
cell lysates were divided into 2 aliquots, one of which
was treated with RNase A. Total RNA from the treated
and the untreated samples were isolated and fractionated
on 2% agarose gel to check for the efficiency of RNase A
treatment (Figure 1C 1st panel). The treated and the un-
treated lysates were then used for immunoprecipitation
with mouse anti-Rev antibody followed by Western blot
with goat anti-hStau-2 antibody. It was observed that
the degradation of ssRNA did not affect the interactions
between Rev and hStau-2 (Figure 1C 2nd and 3rd panels).
Since hStau-2 is a dsRNA binding protein and Rev is
also reported to bind to the structured RRE element, we
checked if the interaction is mediated by any dsRNA.
For this, cell lysates were treated with RNase III which
Figure 1 Rev interacts with hStau-2. A) Co-immunoprecipitation of endogenous hStau-2 with Rev-GFP using anti-Rev antibody and Western
Blot with anti-hStau-2 antibody: HEK293T cells were transfected with Rev-EGFP vector or GFP vector control, cell lysates were prepared after 48
hours followed by IP and WB. Whole cell lysates were checked for Rev expression by anti-Rev antibody. B) Co-immunoprecipitation of endogenous
hStau-2 with Rev-GFP using anti-GFP antibody and Western Blot with anti-hStau-2 antibody: HEK293T cells were transfected with Rev-EGFP vector or
GFP vector control, cell lysates were prepared after 48 hours followed by IP and WB. Whole cell lysates were checked for GFP/Rev-GFP expression by
anti-GFP antibody. C) RNase A treatment and pulldowns: Cell lysates were treated with RNase A. RNA degradation was assessed by RNA isolation from
both RNase A untreated and treated cell lysates and run on 2% Agarose gel (1st Panel). Treated and untreated samples were used for IP with anti-Rev
antibody and WB by anti-Staufen-2 antibody (2nd Panel) and anti-Rev antibody (3rd Panel). D) RNase III treatment and pulldowns: Cell lysates were
treated with RNase III. RNA degradation was assessed by RNA isolation from both RNase III untreated and treated cell lysates and run on 2% Agarose
gel (1st Panel). Treated and untreated samples were used for IP with anti-Rev antibody and WB by anti-Staufen-2 antibody (2nd Panel) and anti-Rev
antibody (3rd Panel).
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noprecipitations were performed as mentioned above and
hStau-2 was detected in the immunoprecipitated samples
(Figure 1D 2nd and 3rd panels). It was clear from this ex-
periment that Rev and hStau-2 interaction is not mediated
by dsRNA either. With this, we concluded that HIV-1 Rev
interaction with hStau-2 is not RNA dependent.
Rev influenced the sub-cellular localization of hStau-2
Rev mediates the transport of RRE-containing viral RNA
across the nuclear membrane by shuttling between the
nucleus and the cytoplasm of an infected cell [31]. hStau-2,
though primarily localizes in the cytoplasm, has also
been shown to shuttle between the nucleus and the cyto-
plasm [26,32]. With both the proteins exhibiting nucleo-
cytoplasmic shuttling properties, we addressed the questionif Rev and hStau-2 co-localize in these sub-cellular com-
partments. The cellular localization of hStau-2 alone and
along with transiently expressed Rev-GFP was determined
in HEK293T cells by confocal microscopy (Figure 2). When
hStau-2 was overexpressed alone in HEK293T cells, it
remained localized to the cytoplasm of the cells (Figure 2
A3-A4). However, when hStau-2 was co-expressed with
Rev-GFP, a fraction of hStau-2 was also observed to be lo-
calized in the nucleoli along with Rev (Figure 2 B3-B5). The
localization of the two proteins was graphically represented
by using twin slicer tool of Huygens Essential software as
discussed in the methodology section [24]. The nuclear
margins are indicated by blue (DAPI staining), hStau-2 is
represented by Red (Alexa Fluor 568) and Rev is shown by
green (GFP). The plots clearly show that hStau-2 when
expressed alone resides primarily in the cytoplasm while in
Figure 2 Localization of Rev and Staufen-2 (hStau-2). A) hStau-2 localizes in the cytoplasm in the absence of Rev: HEK293T cells were transfected
with Staufen-2-59-CMV vector and stained with goat anti-Staufen-2, Rabbit anti-goat Alexa Fluor 568 antibody and nuclear staining by DAPI. B) hStau-2
co-localizes with Rev in both the nucleoli and the cytoplasm: HEK293T cells were transfected with Rev-EGFP and Staufen-2-59-CMV vector. Localization
of GFP-tagged Rev was determined by green fluorescence, hStau-2 was determined by goat anti-Staufen-2, Rabbit anti-goat Alexa Fluor 568 antibody
and nucleus was stained by DAPI. Merged images show co-localization of hStau-2 and Rev. C) Graphical representation of hStau-2 localization in the
absence of Rev: Representative HEK293T cells overexpressing hStau-2 were (C1, C3) used for the distribution plots (C2, C4) using Huygens Essential
software twin slicer tool, where blue line denotes the boundaries of the nucleus and region outside the blue line represent the cytoplasmic region. Red
lines in the plots indicate hStau-2 localization. D) Graphical representation of hStau-2 localization in the presence of Rev: Representative HEK293T cells
over-expressing hStau-2 and Rev-EGFP (D1, D3) were used for distribution plots (D2, D4) using Huygens Essential software twin slicer tool, where blue line
denotes the boundaries of the nucleus and the region outside the blue line represent the cytoplasmic region. Green lines in the plots indicate Rev
localization and Red lines indicate hStau-2 localization. The precise cells whose graphical analyses have been shown are indicated by the white arrows.
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cytoplasm (Figure 2C-D). The merged Rev-GFP and hStau-
2 images (Figure 2 B5 and Figure 2D plots D2 and D4)
show that the two proteins co-localize when expressed to-
gether. With this it was evident that the localization of
hStau-2, which was primarily cytoplasmic, was influenced
in the presence of Rev.
HIV-1 infection up-regulated hStau-2 expression in human
T-lymphocyte and astrocyte cell lines
Human Staufen-1 has been implicated in encapsidation
and assembly of HIV-1 [33-35] whereas both the mam-malian homologs Staufen-1 and Staufen-2 are recruited
in the stress granules of neural cells [30,36]. Apart
from the neural cells, Staufen homologs have also been
shown in other cell types [28,29]. Before any further
characterization of Rev-hStau-2 interactions, we checked
the fate of hStau-2 expression upon HIV-1 infection.
Two HIV-1 permissive human cell-lines, SUP-T1
(Human T cell lymphoblastoma) and 1321 N1 (human
astrocytoma) were used to verify the differential expres-
sion of hStau-2 upon HIV-1 (NL4-3) infection by quan-
titative Real time PCR. hStau-2 expression increased
upon NL4-3 virus infection by 37 ± 18% in SUP-T1
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when compared to the mock infection. The transcript levels
of β-actin were used for normalization of the data.
hStau-2 increased HIV-1 production
With the observation that hStau-2 expression is pro-
moted during HIV-1 infection in human astrocyte and
T-lymphocyte cell lines, we studied the influence of
hStau-2 overexpression on HIV-1 viral titers. hStau-2
was transiently expressed in HEK293T cells 24 hours
prior to transfection with pro-viral DNA pNL4-3.
HEK293T cells were transfected with increasing concen-
tration of hStau-2-59 construct and protein expression
was checked by Western blot using anti-hStau-2 anti-
body (Figure 4A, inset). The viral titers were measured
by p24 ELISA after 48 hours of pNL4-3 transfection. It
was observed that the overexpression of hStau-2 signifi-
cantly increased the viral titers in a dose dependent
manner (Figure 4A). As compared to the control experi-
ment, p24 equivalent of viral titers increased by 56.6 ±
10.28% and 98 ± 3.85% when hStau-2 was overexpressed
using 0.5 μg and 1 μg of hStau-2-59 construct respect-
ively (Figure 4A). To check if the over-expression of
hStau-2 is influencing the viral transcription and in-
creasing the viral output, the total levels of full length
viral transcripts were compared between hStau-2 over-
expressed and control experiments. No significant changes
at the level of full length transcripts were observed with
respect to the control in our experiments (Figure 4B).
Hence, the impact of overexpression of hStau-2 on viral
transcription was ruled out.
The effect of hStau-2 on viral titers was further
confirmed by siRNA mediated knockdown of hStau-2.
hStau-2 specific siRNA and scrambled siRNA were used
for the study. hStau-2 specific siRNA effectively knocked
down hStau-2 transcript levels as quantified through
semi-quantitative RT-PCR (Figure 4C, inset). A dose
dependent reduction in hStau-2 transcript levels wasFigure 3 hStau-2 expression in SUP-T1 and 1321 N1 cell lines upon H
NL4-3 virus. RNA was isolated from both mock and infected cells and qRT-
expression in 1321 N1 cells. The result are from 4 independent experiment
The data were normalized to the transcript levels of β–actin.observed when 20 pmoles and 50 pmoles of hStau-2
specific siRNA were used as compared to scrambled
siRNA (Figure 4C, inset). To check the consequences of
hStau-2 knockdown on HIV progeny synthesis, HEK293T
cells were transfected with pro-viral DNA pNL4-3 after 24
hours of silencing. Cells were harvested after 48 hours
of pNL4-3 transfection and HIV-1 p24 levels from
the culture supernatants were measured by p24 ELISA
(Figure 4C). The knockdown of hStau-2 resulted in a sig-
nificant decrease in HIV-1 titers showing 30.75 ± 8.9% and
57.32 ± 11.82% reduction in p24 equivalent of viral titers
in a dose dependent manner (Figure 4C). Together, these
data confirmed that hStau-2 behaved as a positive regula-
tor of HIV-1 production.
hStau-2 increased RRE containing viral mRNA export
activity of Rev
With the experiments confirming the promotion of
HIV-1 production by hStau-2 in addition to its direct
interaction with Rev, we studied whether hStau-2 can
enhance the RNA export activity of Rev. hStau-2 was
overexpressed in HEK293T cells followed by transfection
with pro-viral DNA pNL4-3. After 24 hours of transfec-
tion, the cells were harvested and cytoplasmic fractions
were separated. Total RNA from the cytoplasmic frac-
tions were extracted. The purity of cytoplasmic fraction
was confirmed by the absence of pre-GAPDH mRNA in
RT-PCR (Additional file 3: Figure S3). The levels of RRE
containing viral RNA in the cytoplasm were then quanti-
fied by real time PCR using RRE specific primers. To
quantify the RRE levels, a standard plot was generated
based on the copy numbers of the amplified RRE region
from the known concentration of RRE-GEM construct
used as a template (Additional file 4: Figure S4A-B).
Compared to the control experiments, hStau-2 overex-
pression promoted the export activity of Rev in a dose
dependent manner as evident by 3 and 4 fold increase
in the levels of RRE containing viral RNA in theIV-1 infection. Cells were infected with 50 ng/ml of p24 equivalent of
PCR was carried out. A) hStau-2 expression in SUP-T1 cells B) hStau-2
s and error bars represent ± SD. *p value≤ 0.05 was taken as significant.
Figure 4 Effect of hStau-2 expression on viral p24 levels. A) Over-expression of hStau-2 increased HIV-1 production: hStau-2 over-expressed
HEK293T cells or control cells were transfected with pNL4-3 pro-viral DNA and scored after 48 hours for p24 by ELISA in the culture supernatant.
The inset shows over-expression of hStau-2 after transfection with increasing concentration of hStau2-59 construct. There was a significant increase in
the p24 levels when 0.5 and 1ug of hStau2-59 construct was used. B) The relative quantification of full length (9 kb) viral transcript. Viral transcripts were
quantified from hStau-2 overexpressed and control cells by qRT-PCR and normalized to β-actin. C) siRNA mediated knockdown of hStau-2 reduced
HIV-1 production: hStau-2 siRNA or scrambled siRNA were transfected one day prior to pNL4-3 transfection in HEK293T cells. Inset: Semiquantitative
RT-PCR gel showing a decrease in hStau-2 expression when hStau-2 specific siRNA was used. The viral p24 levels in the culture supernatant were
progressively reduced when hStau-2 specific siRNA was used in a dose dependent manner. The experiments were done more than 3 times and error
bars represents ± SD. *p value ≤ 0.05 were taken as significant.
Banerjee et al. Retrovirology 2014, 11:18 Page 6 of 15
http://www.retrovirology.com/content/11/1/18cytoplasmic fraction of HEK293T cells (Figure 5A). The
CT values showed a significant shift towards the left
with increasing amounts of hStau-2 expressing vector,
indicating high copy number of RRE-RNA in the re-
spective cytoplasmic fractions (Figure 5B).
To reconfirm that RRE-RNA export activity of Rev
was indeed promoted by hStau-2, endogenous hStau-2was knocked down using siRNA and the above experi-
ment was repeated. HEK293T cells treated with either
scrambled siRNA or hStau-2 specific siRNA (in two in-
creasing amounts) were transfected with equal amount
of pNL4-3 pro-viral DNA. 24 hours post pNL4-3 trans-
fection, the RRE-containing viral RNA was quantified
from the cytoplasmic fractions of these cells by qRT-
Figure 5 Effect of hStau-2 over-expression and knockdown on Rev export activity. A) Over-expression of hStau-2 increased RRE-RNA levels
in the cytoplasmic fraction of HEK293T cells: hStau-2 over-expressed HEK293T cells or control cells were transfected with pNL4-3 pro-viral DNA.
After 24 hrs of pNL4-3 transfection, total RNA was isolated from the cytoplasmic fractions and cDNA was prepared from 500 ng of RNA. Viral RRE
was measured in the cytoplasmic fraction by absolute qRT-PCR. B) A leftward shift in CT curves for RRE-containing RNA upon hStau-2 overexpression.
C) hStau-2 knockdown reduced RRE-RNA levels in the cytoplasmic fraction of HEK293T cells: hStau-2 siRNA or scrambled siRNA were transfected into
HEK293T cells followed by pNL4-3 pro-viral DNA transfection. After 24 hrs of pNL4-3 transfection, total RNA was isolated from the cytoplasmic fractions
and cDNA was prepared from 500 ng of RNA. Viral RRE was measured in the cytoplasmic fraction by absolute qRT-PCR. D) A rightward shift in CT curves
for RRE-containing RNA upon hStau-2 knockdown. The experiments were done more than 3 times and the error bar represents ± SD. *p value ≤ 0.05 was
taken as significant.
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As clear from the plot in Figure 5C, RRE containing viral
RNA in the cytoplasm of the cells were 1.5 and 2.5 fold
less in conditions where hStau-2 was knocked down
using increasing doses of siRNA (Figure 5C). As ex-
pected, a significant right shift in CT curves for RRE-
containing RNA in hStau-2 knocked down cells were
observed when compared to the scrambled siRNA treated
cells (Figure 5D). Collectively, these experiments estab-
lished that the host protein hStau-2, which was upregu-
lated during HIV-1 infection, promoted RRE containing
RNA export activity of Rev and increased HIV-1 titers.
hStau-2 mutant defective in Rev interaction failed to
promote RNA export activity of Rev and viral production
The experiments so far indicated that the presence of
hStau-2 positively regulated Rev RNA export activity
and the viral production. To confirm that the physical
interaction between hStau-2 and Rev is instrumental in
promoting Rev activity, a hStau-2 mutant (referred as
hStau-2Mut) defective in Rev binding was generated.
For this, HIV-1 Rev was docked onto available Staufen-2
homolog to predict the critical residues of hStau-2 thatpossibly interacted with Rev. The best ranked complexes
from three different docking studies (Additional file 5:
Figure S5 A-B) suggested that hStau-2 residues spanning
314–320 are playing an important role in the interaction
with Rev (Figure 6A). Based on these predictions, hStau-
2Mut with mutations Q314R, A318F and K319E was
generated. This mutant was used in the co-immunopre-
cipitation assays to check for its interaction with Rev.
Rev-GFP was co-overexpressed with either the wt hStau-
2 or hStau-2Mut. The cell lysates were confirmed for
the overexpression of Rev, wt hStau-2 and hStau-
2Mut by Western blots (Figure 6B, 1st and 2nd panel).
Immunoprecipitations were performed using mouse
anti-Rev antibody. hStau-2 was detected by Western
blot in the immunoprecipitated samples using goat
anti-hStau-2 antibody (Figure 6B, 3rd panel). It was
observed that mutations, Q314R, A318F and K319E, did
not obliterate the Rev-hStau-2 interactions completely,
though made it defective for Rev binding (Figure 6B).
In order to check if hStau-2Mut defective for Rev
binding had different sub-cellular distribution than the
wt hStau-2, we observed its localization in the presence
or in the absence of Rev by confocal microscopy
Figure 6 Rev-hStau-2 interactions are essential for hStau-2 dependent promotion of Rev activity. A) The docked complex of Staufen
homolog from mouse (1UHZ, grey ribbon) and Rev protein (2X7L, orange ribbon) showing interacting residues: The corresponding residues of
hStau-2 protein are indicated in brackets. B) Co-immunoprecipitation of hStau-2 or hStau-2Mut with Rev using anti-Rev antibody: HEK293T cells
were transfected with Rev-EGFP vector and co-transfected with hStau2-59 or hStau-2Mut-CMV vector, cell lysates were prepared after 48 hours
followed by IP and WB. Whole cell lysates were checked for Rev expression by anti-Rev antibody and for hStau-2 expression by anti-hStau-2
antibody. * indicates non-specific bands or degraded protein. C) Localization of hStau-2Mut. hStau-2Mut localizes in the cytoplasm: HEK293T cells
were transfected with hStau-2Mut-CMV vector and stained with goat anti-Staufen-2, Rabbit anti-goat Alexa Fluor 568 antibody and nucleus was
stained by DAPI. Distribution plot is shown at the end of the panel. D) Co-localization of Rev and hStau-2Mut: HEK293T cells were transfected
with Rev-EGFP and hStau-2Mut-CMV vector. Localization of GFP-tagged Rev was determined by green fluorescence, hStau-2Mut was determined
by goat anti-Staufen-2, Rabbit anti-goat Alexa Fluor 568 antibody and nucleus was stained by DAPI. Merged images show co-localization of
hStau-2Mut and Rev. Distribution plot is shown at the end of the panel. The precise cells whose graphical analyses have been shown are
indicated by the white arrows.
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the sub-cellular regions of the nucleus and the cyto-
plasm was similar to that of the wild type hStau-2. Simi-
lar to the wild type hStau-2, hStau-2Mut localized
primarily to the cytoplasm in the absence of Rev while a
fraction of it localized to the nucleoli in the presence of
Rev (Figure 6C-6D). These studies clearly indicated that
though hStau-2Mut was defective in binding to Rev,
other properties like the sub-cellular localization was
not affected.
We then scored the influence of hStau-2Mut on
the RNA export activity of Rev. The levels of RRE-
containing viral RNA in the cytoplasm of HEK293T cells
transfected with pNL4-3, overexpressing either the wild-
type (hStau-2) or the mutant (hStau-2Mut) hStau-2 were
studied using qRT-PCR (Figure 7A). It was evident that
the cytoplasm of HEK293T cells over-expressing hStau-2
had higher levels of RRE-containing viral RNA com-
pared to the control experiment (pNL4-3) denoting
Rev-supporting function of hStau-2, while the levels ofRRE-containing viral RNA in the cytoplasm of HEK293T
cells that over-expressed hStau-2Mut remained similar to
that of the control experiment (Figure 7A). The CT curve
for RRE-containing RNA for hStau-2 showed a significant
left shift with reference to the CT curve for the control
experiment (Additional file 6: Figure S6 curves A and C),
while no such shift was observed for hStau-2Mut
(Additional file 6: Figure S6 curve B). From these results, it
was inferred that hStau-2 dependent promotion of Rev
activity was not exhibited by hStau-2Mut that was defective
in interacting with Rev. Further, when p24 equivalent of
HIV-1 titers was measured in the culture supernatants
from similar experiments, it was observed that hStau-2
over-expressing cells produced more viruses than the
control experiment, while cells expressing hStau-2Mut
produced less virus particles, even lesser than that
produced in the control experiment (Figure 7B). These
experiments confirmed that the protein-protein inter-
action between Rev and hStau-2 was important for the
modulation of Rev-export activity and viral titers.
Figure 7 Rev-hStau-2 interactions are essential for hStau-2 dependent promotion of Rev activity. Viral RRE-RNA levels were measured in
the cytoplasmic fraction by absolute qRT-PCR for either hStau-2 or hStau-2Mut over-expressing cells. A) hStau-2Mut did not promote RRE-RNA
export activity of Rev: Viral RRE-RNA levels were measured in the cytoplasmic fraction by absolute qRT-PCR for hStau-2, hStau-2Mut over-expressing
cells and the control cells. Concentrations of the plasmid hStau-2 or hStau-2-Mut was 0.1ug and pNL4-3 was 40 ng. B) Viral p24 levels were scored by
p24 ELISA. Concentration of the plasmid hStau-2 or hStau-2-Mut was 0.5ug and pNL4-3 was 40 ng. hStau-2Mut did not increase HIV-1 production.
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This study describes a new host factor, Staufen-2, that
assists in HIV-1 pathogenesis by supporting the activity
of a critical viral regulatory protein, Rev, thereby increas-
ing the viral production in an infected cell. The observa-
tions were supported by over-expression and siRNA
mediated knockdown of hStau-2, where it was evident
that hStau-2 increased the RRE-RNA export activity of
Rev and the viral titers (Figures 4 and 5). Abrogating the
direct interaction between Rev and hStau-2 by generating
hStau-2 mutant defective for Rev binding, abolished
hStau-2 dependent promotion of Rev activity and hence
final viral output. This positive regulator of HIV-1 was also
observed to be upregulated during HIV-1 infection of hu-
man T-lymphocyte and astrocyte cell lines (Figure 3A-B).
Cellular protein, Staufen belongs to dsRNA binding pro-
tein family, first identified in Drosophila [37]. Mammals
possess two Staufen homologs, Staufen 1 and Staufen 2,
each with multiple isoforms and splice variants [38]. Both
the Staufen homologs are reported to form RNA-protein
complexes and participate in transport, stability and decay
of mRNA in human neurons or other polarized cells
thereby regulating the spatial and the temporal gene ex-
pressions [30,39]. Recently, it was deciphered that Staufen
1, despite being a host protein, is selectively packaged in
HIV-1 infectious particle through its interaction with
HIV-1 Gag [34,35], while there were no previous reports
of hStau-2 being involved in any phase of the HIV-1 life
cycle. It was intriguing to identify hStau-2 in the pull-
down samples of Rev as we noticed that Rev, a protein
from the pathogen and hStau-2, a protein from the host,
had overlapping biochemical and functional properties.
Both the proteins bind RNA, shuttle between the nucleus
and the cytoplasm and mediate mRNA transportation
across the nuclear membranes. Earlier reports by inde-
pendent studies showed that CRM1/Exportin-1 caninteract separately with both Rev and hStau-2 and pro-
mote their RNA export activity [32,40]. With our studies
showing that Rev and hStau-2 physically interacted with
each other (Figure 1A and B) and that this interaction pro-
moted the Rev activity (Figure 5), it can be speculated that
together with CRM1 and hStau-2, Rev may form an elab-
orate export complex for the successful transportation or
regulated release of large viral RNA across the nuclear
membrane. It should be noted that the composition of
such multiprotein-RNA complexes may vary across cell
types and would be interesting to explore how the com-
position of such complexes impact the viral RNA trans-
port by Rev.
A number of RNA binding host proteins like RNA
helicase A (RHA), human Rev-interacting protein (hRIP)
etc., interact with Rev and influence its activity [15,41,42].
These interactions are either direct or mediated by other
proteins or RNA. In case of hStau-2, it could be estab-
lished that the interaction with Rev is independent of
RNA (Figure 1C-1D). Though this strongly suggested a
direct protein-protein interaction, we cannot rule out the
possibility of cellular or viral RNA existing between the
two proteins under physiological conditions. Yet another
interesting fact to further decipher would be to identify
the respective RNA partners of hStau-2 and Rev under
varied physiological conditions in different HIV permissive
host cells.
In agreement with the positive regulation of hStau-2
on Rev activity, over-expression of hStau-2 increased
viral titers. The essentiality of the direct protein-protein
interaction between Rev-hStau-2 was established through
hStau-2Mut defective in Rev binding that did not support
the hStau-2 dependent promotion of Rev activity and in-
crease in the viral titers (Figure 7A-B). In fact, the cells
overexpressing hStau-2Mut produced lesser virus than
pNL4-3 alone transfected control cells (Figure 7B). These
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the life cycle of HIV-1 apart from increasing Rev mediated
viral RNA export activity. These studies also demonstrated
that disrupting the protein-protein interaction between
Rev and hStau-2 can prevent hStau-2 from helping viral
production. This information holds high significance
as the Rev-Staufen2 docking studies (Figure 6A and
Additional file 5: Figure S5) can be further exploited to de-
sign peptide based retroviral inhibitors where disrupting
Rev-hStau-2 interactions would limit viral propagation.
Staufen containing RNA granules are a part of high
molecular mass (HMM) complexes of cytoplasmic nu-
cleoproteins. Low Molecular Mass (LMM) A3G when
gets converted into HMM loses its antiretroviral prop-
erty and cannot limit HIV-1 propagation in infected cells
[43,44]. In our observations, hStau-2 expression was up-
regulated upon HIV-1 infection of CD4 + T lymphocyte
cell line SUP-T1. It can be inferred that T-cells, when
activated by HIV-1 infection expressed more hStau-2
that further helped making more Staufen containing
HMM complexes that prevented endogenous LMM-A3G
from inhibiting HIV propagation. This can be one more
approach to explain the high viral production by the in-
fected cells over-expressing hStau-2 apart from the pro-
Rev function of hStau-2. HIV-1 infection upregulated
hStau-2 expressions in astrocytes as well (Figure 3B). It
would be interesting to further study the impact of in-
creased levels of hStau-2 on neuronal cells. Distorted
hStau-2 levels in these cells upon HIV infection may alter
mRNA transport and hence protein expressions that can
explain conditions like HIV associated neuro-dementia.
This study has established the involvement of yet an-
other member of the Staufen family of protein in HIV
pathogenesis, where hStau-2 regulated HIV-1 titers
through direct interaction with one of the key viral pro-
teins. It is evident from our study that one possible
mechanism by which hStau-2 promoted viral production
is by aiding HIV-1 protein Rev in transporting viral
RNA for the synthesis of late viral structural proteins.
Further investigations to elucidate the mode of action of
hStau-2 in context of HIV pathogenesis will add sub-
stantial information for designing new anti-retroviral
strategies.
Conclusion
Conclusively, we have identified host protein hStau-2 as a
positive effector of HIV-1 Rev that promoted its RNA
export activity, thereby facilitating viral production, the
expression of which was upregulated upon HIV-1 infection.
Methods
Cell lines, viral stock production and HIV-1 infection
The cell lines used in the study: HEK293T (human em-
bryonic kidney cell line) obtained from Dr. Reddy’sInstitute of Life Sciences, Hyderabad and Astrocyte 1321
N1 human astrocytoma (gift from Dr. Kondapi) were
maintained in DMEM media (Invitrogen, USA). SUP-T1
(human T cell lymphoblastoma) obtained from Dr. S.
Jameel, ICGEB Delhi was maintained in RPMI-1640
media (Invitrogen, USA). Additionally, the media were
supplemented with 10% fetal bovine serum (Gibco,
USA), 100 U of penicillin/ml and 100 μg of strepto-
mycin/ml (Himedia Laboratories, India). All the cell
lines were grown in 37°C with 5% CO2.
Infectious HIV-1 particles were produced by transfec-
tion of proviral DNA pNL4-3 into HEK293T cells by cal-
cium phosphate method [45]. Culture supernatants were
collected at an interval of 24 hours post transfection, fil-
tered through 0.45 μM syringe filter (Millipore, USA),
precipitated using Polyethylene glycol [45] and quanti-
fied by HIV-1 p24 ELISA kit (Advanced BioScience
Laboratories Inc, USA) according to the manufacturer’s
protocol. The virus thus produced is HIV type 1 (HIV-1)
referred as NL4-3. Cells were infected with 50 ng/ml of
p24 equivalent of NL4-3 virus in the presence of 8 μg/
ml of polybrene (Sigma-Aldrich, USA). After 4 hours of
infection, cells were washed with phosphate buffer saline
(PBS) and kept for 48 hours in complete media. The proto-
col used and standards maintained are approved by Institu-
tional Biosafety Committee, University of Hyderabad.
Plasmids and constructs
His-Rev-setB
Full length cDNA of HIV-1 Rev was amplified from
CMVsrev (gift from Prof. B. K. Felber, Center for Cancer
Research, USA) using primers Rev-His-FP and Rev-His-RP
(Additional file 7: Table S1) and cloned into BglII and NcoI
sites of pRSET-B E.coli T7 Expression Vector (Invitrogen,
USA) to generate hexa-histidine tag at the N-terminal.
Rev-EGFP-C3
The Rev gene was amplified from His-Rev-setB construct
using primers Rev-GFP-FP and Rev-GFP-RP (Additional
file 7: Table S1) and cloned into BglII and SalI site of
pEGFP-C3.
hStau-2Mut-CMV
hStau-2-59 (gift from Prof. Luc Desgroseillers, Université
de Montréal, Canada) was used as a template to create
Human Staufen 2 mutant. The mutant region containing
Q314R, A318F and K319E mutations were generated by
overlap PCR using Stau-2Mut FP and Stau-2Mut RP
(Additional file 7: Table S1) and cloned into SalI and
XbaI site of pCMV-Sport 1 (Invitrogen, USA).
RRE-GEM
Using pNL4-3 as a template, RRE sequence was cloned
into EcoRI and HindIII sites of pGEM-3Zf + (Promega,
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and RRE-RP (Additional file 7: Table S1).
All the constructs were confirmed by sequencing
(Eurofins, India).
Other plasmids used were hStau-2-59 (gift from Prof.
Luc Desgroseillers, Université de Montréal, Canada) for
expression of wild type hStau-2, pro-viral DNA con-
struct pNL4.3 (gift from Prof. A. K. Kondapi, University
of Hyderabad, India), pEGFP-C3 (Clonetech, USA).
Expression and purification of the recombinant Histidine
tagged Rev protein
His-Rev-setB construct was transformed into BL-21 DE3
codon plus (RIL) cells (Agilent technologies, USA) for
expressing recombinant Rev protein with N terminal 6X
histidine tag by induction with 1 mM of Isopropyl β-D-1-
thiogalactopyranoside (IPTG) (Fermentas, Germany) for 6
hours at 37°C. Rev was purified under native conditions
using Talon-affinity resin (Clontech, USA) according to
the manufacturer’s protocol and eluted with 150 mM
imidazole. After purification, Rev protein was dialyzed in
modified Rev-buffer [46] with the composition of 50 mM
sodium phosphate buffer, pH 7.0, 150 mM NaCI, 10 mM
K2S04, and 1 mM DTT. The protein was concentrated
using centricon with 3 kDa cutoff (Millipore, USA). Pro-
tein concentration was measured by 1X Bradford Dye Re-
agent (Bio-Rad, USA) according to the manufacturer’s
instructions. The purified protein was checked on 15%
SDS PAGE (Additional file 1: Figure S1A) and confirmed
by Western blot using 1:2000 dilution of mouse anti-Rev
antibody (SantaCruz Biotechnology Inc., USA) and 1:2500
dilution of HRP conjugated goat anti-mouse IgG antibody
(SantaCruz Biotechnology Inc., USA) followed by detec-
tion with Pierce ECL western blotting substrate (Thermo
Scientific, USA) and visualized using VersaDoc gel im-
aging system (BioRad, USA).
Affinity chromatography to identify Rev interacting host
factors
Affinity column was prepared using recombinant His-Rev
protein according to the previously described protocol
[47] with some modifications. In brief, 100 μg of recom-
binant His-Rev was added to the 500 μl of Talon resin
and incubated for 4 hours at 4°C. Wash with Rev buffer
(50 mM sodium phosphate buffer, pH 7.0, 150 mM NaCI,
10 mM K2S04, and 1 mM DTT) was given to remove the
unbound Rev protein. SUP-T1 cells were lysed by lysis
buffer (50 mM Tris–HCl pH 7.5, 150 mM NaCl, 2% Gly-
cerol, 5 mM DTT, 0.1% NP-40, 1 mM PMSF and protease
inhibitor cocktail), centrifuged to remove debris and
supernatant from which 1 mg of total protein was added
to the Rev bound Talon resin. As a control, SUP-T1 cell
lysates were added to the column without bound re-
combinant His-Rev protein. After overnight incubation,columns were washed 5 times with wash buffer (Rev buf-
fer + 50 mM imidazole). The samples were eluted using
elution buffer (Rev buffer + 150 mM imidazole). 40 μl of
eluted samples from both test and control columns were
subjected to SDS PAGE followed by silver staining [48].
Bands unique to Rev affinity column pull-down were
excised (Additional file 1: Figure S1B) and identified using
MALDI-TOF (Bruker Daltonics, Bremen, Germany) at
proteomics facility of the University of Hyderabad, India.
Protein bands were identified using database searches
(PMF and MS/MS) using MASCOT program by Biotools
software (Bruker Daltonics) (Additional file 1: Figure S1C
and Additional file 2: Figure S2).
Immunoprecipitations
Transfected HEK293T cells were washed with PBS and
lysed in IP-Buffer [20 mM Tris HCl pH 8.0, 137 mM
NaCl, 10% glycerol, 1% Nonidet P-40 (NP-40)]. Cells
were sonicated and centrifuged at 12000 rpm at 4°C to
remove cellular debris. For RNA digestion, cell lysates
were treated either with RNase A or with RNase III
as per the manufacturer’s protocol. Agarose A/G beads
(SantaCruz Biotechnology Inc., USA) were washed with
IP buffer and incubated with cell lysates for 2 hours at 4°
C to remove proteins that non-specifically bind to the
beads (pre-clearing step). After pre-clearing, the beads
were centrifuged at 4000 rpm and the supernatant
was added to the new column containing A/G beads
already conjugated with mouse anti-Rev antibody or
anti-GFP antibody for 4 hours at 4°C on a rocker.
After 4 hours of incubation, samples were washed 3
times with IP buffer. The samples were processed for
Western blot.
Western blot
Samples were fractionated on 10% SDS–PAGE and
transferred to methanol treated PVDF membrane (GE-
Amersham, USA) in a Western blot transfer apparatus.
After the membranes were blocked with 5% non fat milk
for 1 hour at RT, the primary antibody was added to the
membrane and incubated overnight at 4°C on a rocker.
The antibody dilution used for mouse anti-Rev antibody
was 1:1000 (SantaCruz Biotechnology Inc., USA), for
mouse anti-GFP antibody was 1:1000 (SantaCruz Bio-
technology Inc., USA) and for goat anti-Stau-2 antibody
was 1:500 (SantaCruz Biotechnology Inc., USA). After 3
washes with PBS-T (PBS + 0.05% Tween 20), the mem-
branes were incubated with the respective HRP conju-
gated antibodies namely, goat anti mouse IgG with
1:2000 dilution (SantaCruz Biotechnology Inc., USA)
and donkey anti-goat IgG with 1:1000 dilution (Santa-
Cruz Biotechnology Inc., USA) for respective detection
of Rev, GFP and hStau-2 at RT for 1 hour. Following 3
washes with PBS-T, ECL substrate (Super Signal West
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to the membranes and was scanned using Versadoc sys-
tem (Biorad). The Western blot images were quantified
by Image-J software (NIH).
Immuno-fluorescence microscopy
For fluorescence studies, cells were grown on coverslips
one day before transfection. Cells were transfected with
respective plasmids using lipofectamine LTX plus re-
agent (Invitrogen, USA). After 48 hours of transfection,
cells were washed twice with PBS and fixed in 3% para-
formaldehyde. Fixed cells were washed 3 times with
PBS to remove excess of paraformaldehyde and perme-
abilized by adding ice-cold methanol for 5 min at −20°C.
Cells were washed thoroughly and mounted with DAPI.
Rev-GFP exhibited green fluorescence. hStau-2 was de-
tected using polyclonal anti-hStau-2 antibody and corre-
sponding secondary fluorescent-tagged, Alexa Fluor® 568
rabbit anti-goat IgG antibody (red). The nuclei of the
cells were stained with DAPI (blue). Cells were seen under
Leica confocal TPS2 microscope at 20X magnification and
analyzed using Leica software. For localization in the cyto-
plasm or the nucleus, several fields were scanned and
Huygens Essential software was used to plot graph repre-
senting fluorescence intensities of blue (for nucleus), green
(for Rev) and red (for Staufen-2) channels across the cells
using twin slicer tool [24].
Quantitative Real time PCR
RNA was isolated using Trizol reagent (Invitrogen, USA)
according to the manufacturer’s protocol. cDNA was
prepared from RNA by using Superscript III (Invitrogen,
USA) and oligo dT (Fermentas, Germany ) at 50°C for 1
hour followed by inactivation at 70°C for 15 min. hStau-
2 and β-actin genes were amplified by SYBR Premix
ExTaq (Takara Bio Inc, Japan) in Eppendorf Mastercycler
Realplex2 (Eppendorf, Germany). The fold difference
was calculated using the formula 2-(ΔΔCT). The primers
used were Stau-RT-FP, Stau-RT-RP, Actin-RT-FP and
Actin-RT-RP mentioned in Additional file 7: Table S1.
Transfection and silencing
HEK293T cells were seeded one day before transfection
at 70% confluency. Cells were washed with PBS and
transfected with plasmids using Lipofectamine-LTX plus
reagent (Invitrogen, USA). After 48 hours of transfec-
tion, cells were harvested.
To silence hstau-2 gene, a 21 bp duplex siRNA was
synthesized for a selected region of hStau-2. As a con-
trol, scrambled siRNA was used. hStau-2 specific siRNA
(20 and 50 picomoles) or scrambled siRNA (50 pico-
moles) were transfected using Lipofectamine RNAiMAX
reagent (Invitrogen, USA). The synthesized siRNA were
tested for knockdown efficiency in preliminary experimentsby semi-quantitative RT-PCR using Stau-RT-FP and Stau-
RT-RP primers for 25 cycles (Additional file 7: Table S1).
β-actin was used as a control for the experiment. The reac-
tion without reverse transcriptase was used as a negative
control to confirm that RNA preparation is free of DNA
contamination.
After 24 hours of siRNA treatment, cells were trans-
fected with pNL4-3 plasmid and kept for additional 48
hours.
Quantification of total viral transcripts
For quantification of total viral RNA transcripts, equal
amount of cDNA was used to amplify 9 kb product
by qRT-PCR using primer set TAR-FP and 9 kb-RP
(Additional file 7: Table S1) as described earlier [34].
The fold difference was calculated using the formula
2-(ΔΔCT) and normalized with β-actin levels.
Quantification of RRE-RNA export activity of Rev
HEK293T cells were transfected with hStau2-59 with
lipofectamine LTX plus reagent (Invitrogen, USA) for
overexpression. After 24 hours of rest, cells were trans-
fected with equal amount of pNL4-3. After 48 hours of
hStau-2 transfection, cells were harvested and cytoplas-
mic RNA was isolated using Paris kit (Ambion, USA).
RNase free DNase I treatment was given to remove
DNA contamination. 2 μg of RNA from each group were
reverse transcribed using SuperScript III Reverse Tran-
scriptase (Invitrogen, USA), random hexamer at 50°C for
1 hour followed by inactivation at 70°C for 15 min. For
absolute real time PCR, standard was made using serial
dilution of RRE-GEM construct containing known copy
numbers (Additional file 4: Figure S4). The FAM labeled
RRE taqman probe was commercially designed and syn-
thesized (Invitrogen, USA). 500 ng of cytoplasmic RNA
was reverse transcribed and then PCR amplified using
probe, taqman universal mix II with UNG (Invitrogen,
USA) and checked for the number of copies of RRE
representative of unspliced RNA. UNG glycosylase was
added to remove any carryover of PCR. Background
reading was checked by analyzing negative RT control.
Nuclear contamination in cytoplasmic fraction was
checked by PCR amplification by pre-GAPDH primers
(Additional file 3: Figure S3).
HIV-1 Rev-hStau-2 protein-protein docking
The structure of the Rev protein is available in PDB
(2X7L), and chain M of this protein was used to perform
the docking study with Staufen homologs. As the struc-
ture of hStau-2 is not available, the sequence of hStau-2
was used in a BLASTP search [49] against PDB for find-
ing suitable homologs. The homology search revealed
that the N-terminal of the hStau-2 protein (Residues 6
to 70) had 39% sequence similarity with Dsrm domain
Banerjee et al. Retrovirology 2014, 11:18 Page 13 of 15
http://www.retrovirology.com/content/11/1/18of spermatid perinuclear RNA-binding protein of human
(2DMY), amino acid residues 201–275 had 57% identity
with the Staufen protein from Drosophila (1EKZ) and
amino acid residues 308–383 had 96% identity with the
dsRNA binding domain in Staufen homolog (PDB id:
1UHZ) from mouse. Three different docking studies
were performed between the known Rev structure and
each of the homologs obtained for hStau-2. PatchDock
[50,51] server with refinement tool FireDock [52,53]
were used for molecular docking. PatchDock provided
results which were ranked according to geometric shape
complementarity score after molecular shape representa-
tion and surface patch matching. These results were
used for further refinement and re-scoring of 1000 top
scoring complexes using FireDock. The results from
Firedock ranked the complexes according to the global
energy score. The best docking model with the Staufen
homolog of mouse (1UHZ) and HIV-1 Rev (2X7L) is
shown in Additional file 5: Figure S5B and Figure 6A.
The global energy function of this complex was calcu-
lated by FireDock server to be −7.05 of relative units
(this value is considered to be related to free binding
energy and higher negative value means higher free
binding energy and thus higher interaction probability).
Using this model, the residues which are forming inter-
molecular interactions like hydrogen bonds, electrostatic
and hydrophobic interactions among these two protein
structures were identified. The interacting residues be-
tween Rev and hStau-2 for this model were also pre-
dicted by cons-PPISP server [54,55]. The best ranked
docked complexes between Staufen homolog of mouse
(1UHZ) and HIV-1 Rev protein (2X7L) suggested that
the possible residues of hStau-2 that can bind HIV-1
Rev resided in the regions 232–235, 255–262, 314–320
and 370–375. Subsequent mutation studies were carried
out to validate this prediction. One such hStau-2 mu-
tant, carrying the mutations Q314R, A318F and K319E,
was found defective in binding Rev.
Statistical analyses
All the experiments were performed more than three times
or as mentioned in figure legends. Average values of the ex-
periments are plotted and error bars represent ± SD (stand-
ard deviation). Statistical analyses were done with Student’s
t-test and the significance expressed as p value ≤0.05.
Additional files
Additional file 1: Figure S1. Identification of human Staufen-2 (hStau-2)
as Rev interacting factor through affinity column chromatography. A)
Purification of recombinant Histidine tagged Rev protein: Recombinant
Rev protein was purified from BL-21 DE3 codon plus (RIL) cells and checked
on 15% SDS PAGE followed by Coomassie Staining. Rev was purified to
homogeneity and showed a band ~18 kDa. 1 and 2 denotes two batches
of eluted purified.protein. B) Purified protein was used as bait to pull down Rev interacting
factors from SUP-T1 lysates: Representative gel showing fractionation of pull
down samples from 3 experiments (T1, T2 and T3). Lanes C1, C2 and C3
represent control experiments where SUP-T1 cell lysates were incubated
with Talon resin without Rev. M represent protein marker and rec-Rev
represents the purified protein. Arrows indicate the bands excised for MALDI
analyses from this gel. The experiment was repeated more than 10 times
and protein bands were excised from several gels and given for MALDI
analysis. C) Table showing partial list of proteins identified as Rev interacting
host factors from affinity chromatography experiments which were
repeatedly identified in several pull down assays. The list included Staufen-2.
Additional file 2: Figure S2. Mascot search result and score histogram
for Staufen-2.
Additional file 3: Figure S3. Reverse Transcriptase-PCR to check the
purity of the cytoplasmic fractions: Cytoplasmic fractions were separated
and RNA was isolated using PARIS kit. cDNA was prepared from isolated
RNA and amplified by β-actin and pre-GAPDH primers as mentioned in
the Table S1. Absence of pre-GAPDH band in cytoplasmic fraction is
indicative of the purity of cytoplasmic fraction which showed amplified
β-actin band and not pre-GAPDH band.
Additional file 4: Figure S4. RRE standard plots. Concentration of RRE
template (construct RRE-GEM) was determined spectrophotometrically
and the number of copies was determined for each dilution. A) FAM
labeled Taqman probe was designed against RRE. Fluorescence intensities
of RRE standards were plotted against their respective CT values. B)
Standard curve of CT value vs amount. This standard curve was used for
determining copy numbers of unknown samples.
Additional file 5: Figure S5. Docking studies to predict hStau-2 amino
acid residues that can possibly interact with Rev: A) The alignment of
hStau-2 with the mouse homolog of Staufen: The residues which are
mutated are highlighted in the alignment. B) The docked complex of
Staufen homolog (1UHZ) and Rev protein (2X7L): The HIV-1 Rev protein
is depicted in ribbon and hStau-2 protein in spacefill to show the
probable binding sites. The interacting residues in Staufen are shown
as sticks and are labeled.
Additional file 6: Figure S6. CT value curve for RRE export by wt
hStau-2 and hStau-2Mut overexpression: A leftward shift in the CT curve
of viral RRE levels upon hStau-2 overexpression (curve A) though no such
shift is observed in hStau-2Mut overexpression which remained similar to
the control experiment (curve B and C).
Additional file 7: Table S1. Primers used in the study.
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